Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Vertex Pharmaceuticals    VRTX

VERTEX PHARMACEUTICALS (VRTX)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Vertex Pharmaceuticals
Discovers and develops novel, small molecule pharmaceuticals

Vertex Pharmaceuticals, Inc. engages in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases.

It focuses on development and commercializing therapies for the treatment of cystic fibrosis; infectious diseases, including viral infections, such as influenza, and bacterial infections; autoimmune diseases, such as rheumatoid arthritis; cancer, inflammatory bowel disease; and neurological disorders, including pain, Huntington's disease and multiple sclerosis.

The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.

Number of employees : 2 150 persons.
Sales per Businesses
20152016Delta
USD (in Million)%USD (in Million)%
KALYDECO631.6761.2%703.4341.3% +11.36%
ORKAMBI350.6634%979.5957.5% +179.35%
INCIVEK17.991.7%0.6100% -96.61%
Sales per Regions
20152016Delta
USD (in Million)%USD (in Million)%
United States763.3273.9%1,32277.7% +73.17%
Europe219.6021.3%320.4618.8% +45.93%
Other49.424.8%59.913.5% +21.22%
Managers
NameAgeSinceTitle
Jeff Leiden622009Chairman, President & Chief Executive Officer
Ian F. Smith522001Chief Operating Officer & Executive Vice President
Thomas Graney CFA, MBA532017Chief Financial Officer & Senior Vice President
Jeffrey A. Chodakewitz, MD622014Chief Medical Officer & Executive Vice President
David Matthew Altshuler MD, PhD532012Chief Scientific Officer & EVP-Global Research
Reshma Kewalramani-2017Senior VP-Clinical Development & Medical Affairs
Bruce I. Sachs, MBA581998Lead Independent Director
Elaine S. Ullian701997Lead Independent Director
Margaret G. McGlynn, MBA592011Independent Director
Terrence C. Kearney, MBA632011Independent Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 252,902,848 251,875,627 99.6% 0 0.0% 99.6%
Shareholders
NameEquities%
T. Rowe Price Associates, Inc. 26,478,714 10.5%
The Vanguard Group, Inc. 17,185,814 6.80%
Fidelity Management & Research Co. 15,597,963 6.17%
Wellington Management Co. LLP 13,267,346 5.25%
BlackRock Fund Advisors 13,154,912 5.20%
SSgA Funds Management, Inc. 11,218,527 4.44%
Capital Research & Management Co. (World Investors) 7,374,579 2.92%
ClearBridge Investments LLC 7,080,171 2.80%
JPMorgan Investment Management, Inc. 6,285,584 2.49%
Jennison Associates LLC 6,017,766 2.38%
Holdings
NameEquities%Valuation
Crispr Therapeutics AG (CRSP) 3,186,5867.77%74,821,039 USD
Markets and indexes
- Nasdaq Stock Market
- Nasdaq Global Select Market
- Nasdaq 100 / SP 500
Stock Exchange Codes
- Bloomberg Code :  VRTX:US
- Reuters Code :  VRTX.O
- Datastream Code :  
Company contact information
Vertex Pharmaceuticals
50 avenue Northern
MA 02110 Boston, Massachusetts
États-Unis (les)

Phone : +1 617 444 6100
Fax : +1 617 444 6680
Internet : http://www.vpharm.com
Sector Bio Therapeutic Drugs
1st jan.Capitalization (M$)
VERTEX PHARMACEUTICALS4.76%39 951
GILEAD SCIENCES14.10%105 754
REGENERON PHARMACEUTICALS-0.50%39 917
GENMAB10.50%11 762
EXELIXIS, INC.-9.57%8 284
BLUEBIRD BIO INC2.25%8 064
JUNO THERAPEUTICS INC51.50%7 742
NEUROCRINE BIOSCIENCES, INC.-2.20%7 140
BIOVERATIV INC15.58%6 937
TONGHUA DONGBAO PHARMACEUTICAL CO., LTD.9.39%6 614
BIOCON LTD0.19%5 353
BEIGENE LTD (ADR)5.02%5 123
PEPTIDREAM INC13.49%4 839
SAREPTA THERAPEUTICS INC11.14%4 032
HUALAN BIOLOGICAL ENGINEERING INC--.--%3 988
TESARO INC-23.37%3 476
AVEXIS INC-0.45%3 461
AGIOS PHARMACEUTICALS INC23.02%3 407
BEIJING SL PHARMACEUTICAL CO LTD--.--%3 356
LOXO ONCOLOGY INC7.47%2 899
CLOVIS ONCOLOGY INC-19.22%2 782
Connections : Vertex Pharmaceuticals
Accelerated Cure Project for Multiple Sclerosis
American Academy of Arts & Sciences
Charles River Ventures, Inc.
The American Institute of Certified Public Accountants
GreatCall, Inc.
Institute of Chartered Accountants in England & Wales
Institute of Medicine
The Financial Executives Institute
SimpliVity Corp.
Massachusetts Mutual Life Insurance Co.
OneCloud Software, Inc.
Association of American Physicians
Biotechnology Innovation Organization
The Brigham & Women's Hospital, Inc.
National Academy of Sciences
Infectious Diseases Society of America
Nantero, Inc.
The American Society for Clinical Pharmacology & Therapeutics
SpiderCloud Wireless, Inc.
Vertex Pharmaceuticals
DataGravity, Inc.
New England Aquarium Corp.
Jibo, Inc.
Abington Friends School
iControl Networks, Inc.
PathAI, Inc.
The Museum of Fine Arts
Whitehead Institute for Biomedical Research
HCU Network America
American Society for Clinical Investigation
The Boston Private Industry Council, Inc.
Macp Organization
Orphan Technologies Ltd.
The Broad Institute, Inc.
Massachusetts Institute of Technology
© 2018 People , Fundamentals and Ownership    © 2018 Cofisem